Since 2021, IntegraGen's expertise in genomic sequencing and bioinformatics has been associated and integrated within OncoDNA, adding significant value to its oncology services offering. For over two years, our teams have worked to enable OncoDNA to offer a more integrated range of services and products than ever before. To ensure that this consolidated offering is clearly visible to our partners and stakeholders in the oncology field, the trade name IntegraGen becomes OncoDNA. Find our complete service offer on

Legally, the company's structure, characteristics, and contact information remain unchanged.

Genomic Pharma Services

Learn more


Learn more
Integragen investors stock


Learn more

Latest news // Archive